SUBSCRIBE
SUBSCRIBE
News   FDA

OBS Medical Announces FDA Clearance of New Patient Safety Technology

October 1, 2007 | 
1 min read
INDIANAPOLIS--(BUSINESS WIRE)--OBS Medical announced today that the Food and Drug Administration has granted 510(k) clearance for the company to market its next generation patient deterioration early warning system (VisensiaTM) in the United States.
FDA Approvals
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Handmade signboard with Closed inscription and striped rope hanging on pin on bright red background
Company closure
Bespoke Startup EveryONE Folds 1 Week After Plausible Mechanism Guidance
March 4, 2026
 · 
2 min read
 · 
Tristan Manalac
Dream Birds Flying Away, the birds flying out of a bird an open cage, the birds released from a cage, freedom concept. birds set free vector illustration.
Gene therapy
Intellia’s CRISPR Gene Therapy Free To Move Forward After FDA Fully Lifts Hold
March 3, 2026
 · 
2 min read
 · 
Tristan Manalac
Illustration showing hurdles along a path ending in an arrow
Complete response letters
REGENXBIO’s Hunter Rejection Hinged on Inadequate Controls, Surrogate Endpoint
March 3, 2026
 · 
2 min read
 · 
Tristan Manalac
Man walking on a long wavy path with flag at the end, persistence, determination and ultimate business success - 3D Render
Rare disease
UniQure Eyes Phase 3 for Huntington’s Gene Therapy Despite Makary’s Apparent Criticism
March 2, 2026
 · 
3 min read
 · 
Heather McKenzie